Showing results (1201-1210 of 9,006) with videos related to

Sort By:
Pageof 901
European Journal of Clinical Pharmacology|January 17, 2025
Population pharmacokinetic model of tranexamic acid in patients who undergo cardiac surgery with cardiopulmonary bypassTsuyoshi Nakai, Takahiro Tamura, Yasuhiro Miyagawa, et al.
European Journal of Clinical Pharmacology|December 27, 2024
Estimated equipotent conversion ratios of morphine, sufentanil and fentanyl as continuous infusion in neonatal intensive care units: a pharmacoepidemiologic cohort studyManon Tauzin, Inès Cavalier, Matthieu Ortala, et al.
European Journal of Clinical Pharmacology|March 13, 2025
Evaluation of surrogate endpoints in phase III randomized control trials of advanced hepatocellular carcinoma treated with immune checkpoint inhibitorsKe Jiang, Miaowen Liu, Xiao Zhao, et al.
European Journal of Clinical Pharmacology|December 2, 2024
Identification of the most cost-saving disease-modifying therapies and factors affecting the budget in the pharmacotherapy of multiple sclerosis: a systematic reviewMatin Jafari, Mehrshad Sebty, Shaghayegh Moradi, et al.
European Journal of Clinical Pharmacology|December 20, 2024
A Study Of the effect of Sex on drug dosing, concentrations, and pharmacogenomics in the Montreal Heart Institute Hospital Cohort (SOS-PGx): methodology and research progressMarc-Olivier Pilon, Jessica Hindi, Isabelle St-Jean, et al.
European Journal of Clinical Pharmacology|November 25, 2024
Effects of drugs on the oxygen dissociation curve-a scoping reviewThomas Haller, Lukas Lesser, Simon Woyke
European Journal of Clinical Pharmacology|November 21, 2024
Leveraging machine learning in limited sampling strategies for efficient estimation of the area under the curve in pharmacokinetic analysis: a reviewAbdullah Alsultan, Abdullah Aljutayli, Abdulrhman Aljouie, et al.
European Journal of Clinical Pharmacology|September 16, 2024
Sodium-glucose cotransporter 2 inhibitors and renal cancer in the US FDA adverse event reporting systemBo Xu, Jiecan Zhou
European Journal of Clinical Pharmacology|September 12, 2024
Preventive effects of first-generation antihistamine on emergence agitation or delirium: a systematic reviewKazumasa Kotake, Satoru Matsunuma, Naoya Kitamura, et al.
European Journal of Clinical Pharmacology|October 29, 2024
Effects of olanzapine in the improvement of body weight and appetite in patients with cancer or receiving chemotherapy: a systematic review and meta-analysisLu Yuan, Xin-Yu Li, Lu Xu, et al.
Pageof 901